Status:
UNKNOWN
Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers
Lead Sponsor:
Rennes University Hospital
Conditions:
Iron Metabolism Disorders
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
The aim of this study is to measure the variations of serum and urinary hepcidin levels following a single intravenous injection of erythropoietin in healthy volunteers. Hepcidin is a major regulator ...
Eligibility Criteria
Inclusion
- healthy volunteers
- male aged 18 - 30
- normal routine laboratory values
- normal ECG
- normal iron status
Exclusion
- C282Y mutation of the HFE gene
- alcohol or tobacco consumption
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00687518
Start Date
March 1 2008
End Date
February 1 2009
Last Update
May 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unité d'Investigation Clinique - Centre d'Investigation Clinique - Hôpital de Pontchaillou
Rennes, France, 35033